Close

Maxim Group Starts Ritter Pharmaceuticals (RTTR) at Buy, $7 PT

April 13, 2016 4:48 PM EDT Send to a Friend
Maxim Group initiates coverage on Ritter Pharmaceuticals (NASDAQ: RTTR) with a Buy rating and a price target of $7.00.Analyst Jason ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login